Gannon, Steven

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gannon, Steven's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
491.03
Quantity 42,408 -35.9%
Value US$3,198,129
Transaction date
Sale
Price
13.40
Quantity 92,881 +12.7%
Value US$611,538
Transaction date
Sale
Price
298.52
Quantity 30,524 -30.9%
Value CA$435,725
Transaction date
Sale
Price
46.30
Quantity 5,000 -55.6%
Value CA$231,512
Transaction date
Sale
Price
46.25
Quantity 5,000 -35.7%
Value CA$231,250
Transaction date
Sale
Price
46.45
Quantity 1,000 -6.7%
Value CA$46,450
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-11
S Sale
42,408 -35.9%
491.03
US$3,198,129 		42,408 -35.9% 491.03 US$3,198,129
2025-06-10 2025-06-05
S Sale
92,881 +12.7%
13.40
US$611,538 		92,881 +12.7% 13.40 US$611,538
2024-03-12 2024-03-07
S Sale
30,524 -30.9%
298.52
CA$435,725 		30,524 -30.9% 298.52 CA$435,725
2024-03-12 2024-03-07
S Sale
5,000 -55.6%
46.30
CA$231,512 		5,000 -55.6% 46.30 CA$231,512
2024-03-12 2024-03-07
S Sale
5,000 -35.7%
46.25
CA$231,250 		5,000 -35.7% 46.25 CA$231,250
2024-03-12 2024-03-07
S Sale
1,000 -6.7%
46.45
CA$46,450 		1,000 -6.7% 46.45 CA$46,450